Advertisement

Picture EBD Group World of Partnering Opportunities 650x100px

Persons > All

Find below all kinds of persons from France & Monaco.

Total search results: 2420 | Ordered by Person (ascending)
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25  next pagenext page

order ascendingorder descendingPerson order ascendingorder descendingPosition order ascendingorder descendingOrganisation (Group) order ascendingorder descendingRegion
Volckmann, Jacques (Sanofi 202312 VP RnD France) Research & Development Manager Sanofi (Group) [since May 2011] Île-de-France (region)
von Autenried, Paul (BMS 202003 Chief Information Officer) Chief Information Officer (CIO) / Chief Digital Officer Bristol Myers Squibb (BMS) (Group) New York (federal state)
von Braunmühl, Benedikt (Rentschler 202309– CEO before HMNC Brain Health + Medicover AB + Qiagen + Chiron Vaccines) Chief Executive Officer (CEO) Rentschler (Group) Baden-Württemberg (federal state)
von Gabain, Alexander (Intercell 200311) n. a. Valneva (Group) Wien (state)
von Schulthess, Konstantin (CDR-Life 202204 CFO) Chief Financial Officer (CFO) CDR-Life AG Zürich (region)
von Walcke-Wulffen, Vincent-Joachim (BioKryo GmbH 201110 Managing Director) Managing Director Air Liquide (Group) Saarland (federal state)
Vonderscher, Jacky (Enyo Pharma 201602 CEO) Chief Executive Officer (CEO) Enyo Pharma S.A. Auvergne-Rhône-Alpes (region)
Vorobev, Anton (Volta Medical 202101 CFO) Chief Financial Officer (CFO) Volta Medical (Group) Provence-Alpes-Côte d’Azur (region)
Vuillermet, Axelle (NewCap. 201203 Public Relations Manager) Public Relations Manager / Investor Relations Manager NewCap. – Investor Relations & Financial Communications Île-de-France (region)
Waanders, Gary (AC Immune 202111– Head of IR + Communications before Medigene + Bryan Garnier + Zeus Capital + Nomura) Public Relations Manager / Investor Relations Manager AC Immune S.A. (Nasdaq: ACIU) Région Lémanique (region)
Wacker, Ron (SGS 201106– Global BusDev Manager Food Testing before Danone + Chimera Biotec) Business Development Manager / Strategy Manager SGS (Group) Région Lémanique (region)
Wagner, Julian (Pevion Biotech 201110 Business Development) Business Development Manager / Strategy Manager Pevion Biotech AG Espace Mittelland (region)
Wagtmann, Nicolai (Innate Pharma 201507 CSO) Chief Scientific Officer (CSO) / Chief Development Officer (CDO) Innate Pharma S.A. (Euronext Paris: IPH, Nasdaq: IPHA) Provence-Alpes-Côte d’Azur (region)
Wahr, Christine M. (McDermott Will & Emery 201709 Associate in Boston) Attorney / Lawyer McDermott Will & Emery (MWE) (Group) Massachusetts (federal state)
Waicenberg, Jeremie (Mérieux 202104 Senior Business Analyst at Mérieux Equity Partners) Analyst (Financial / Industry) Mérieux (Group) Auvergne-Rhône-Alpes (region)
Wakefield, James (Novacyt 201704 Board Chairman) Board member, non-executive Novacyt (Group) Île-de-France (region)
Waksal, Harlan W. (Kadmon 202109 CEO) Chief Executive Officer (CEO) Sanofi (Group) [since May 2011] New York (federal state)
Walker, Jerry (Lab21 –200710– CEO) Chief Executive Officer (CEO) Novacyt (Group) South East England (region)
Waller, Ivana (Accovion 201010 COO) Chief Operating Officer (COO) Clinipace (Group) Hessen (Hesse) (federal state)
Wallnöfer, Andreas (Jeito Capital 202202– Partner Investor before BioMedPartners + Roche) Partner (venture partner) Jeito Capital (Group) Île-de-France (region)
Walls, Matthew (EpiStem 200704 CEO) Chief Executive Officer (CEO) Genedrive (Group) North West England (region)
Walmsley, Emma (GSK 201704– CEO before CEO of GSK Consumer Healthcare division joined GSK 2010 from L’Oréal) Chief Executive Officer (CEO) GSK (Group) United Kingdom (state/region unspecified)
Walrafen, Luc (Scipio Bioscience 202206 CFO) Chief Financial Officer (CFO) Scipio Bioscience SAS Île-de-France (region)
Walrafen, Pierre (Scipio Bioscience 201711 CEO) Chief Executive Officer (CEO) Scipio Bioscience SAS Île-de-France (region)
Walsh, Christopher (Harvard Univ 200603 Professor + co-founder Genzyme + Vicuron Pharmaceuticals) Professor Harvard University Massachusetts (federal state)
Walter, Monika (Hyglos 2010 Manager Operations) Chief Operating Officer (COO) Mérieux (Group) Bayern (federal state)
Wang, Bing C. (Cellectis 202202– CFO before Refuge Biotechnologies + Barclays Capital + Citigroup Global Markets) Chief Financial Officer (CFO) Cellectis (Group) Île-de-France (region)
Wang, Daniel D. (TUS-Holdings 202002 CEO of Tuspark Europe) Managing Partner (investment firm) TUS-Holdings (Tuspark) (Group) Europe_ooo
Wang, Haixang (APG Bio (CN) 201706 CEO) Sales Manager / Marketing Manager Shanghai (province)
Wanner, Sarah-Christine (Bayer 202003 External Innovation + Partnering) n. a. Bayer (Group) Berlin (federal state)
Ward, Nagib (Deinove 201307– VP Business Development before Novozymes North America Inc) Business Development Manager / Strategy Manager Deinove S.A. (Euronext Growth: ALDEI.PA) Île-de-France (region)
Watt, Alan (NodThera Ltd 201806 CSO + acting CEO) Chief Scientific Officer (CSO) / Chief Development Officer (CDO) NodThera Ltd. East of England (region)
Wattin, Martin (Contur Software AB 201105 CEO) Chief Executive Officer (CEO) Dassault Systèmes (3DS) (Group) Stockholm (region)
Waymel, Bertrand (Novasep 201505– promoted to Group Human Resources Director joined Novasep in 2012) Human Resources Manager Novasep (Group) Grand Est (Great East) (region)
Weber, Matthias-Wilbur (Eurofins 200701–201412 CFO died 12/14) Chief Financial Officer (CFO) Eurofins (Group) Pays de la Loire (region)
Weinand, Dieter (Sanofi 201811– Head Primary Care Unit before Bayer + Otsuka + Pfzer + BMS) President/Director/Head Business Group/Unit/Division Sanofi (Group) [since May 2011]
Weinberg, Serge (Sanofi 201906 Board Chairman) Board member, non-executive Sanofi (Group) [since May 2011] Île-de-France (region)
Weiner, Aaron (Coatue Management 202110 Managing Director + Head of Healthcare) Managing Director Coatue Management
Weir, Neil (Sitryx Therapeutics 201804– CEO before UCB SVP Discovery) Chief Executive Officer (CEO) Sitryx Therapeutics Ltd. South East England (region)
Weiss, Mario (GAIA 201702 CEO + Founder) Chief Executive Officer (CEO) GAIA AG Hamburg (federal state)
Welch, William J. (Bill) (Sequenom 201101– SVP Diagnostics before Monogram 200803– before Dade Behring before La Jolla) Sales Manager / Marketing Manager LabCorp (Group) California (federal state)
Welsh, Chris (Consilium Strategic Communications 201707) Public Relations Manager / Investor Relations Manager ICR (Group) Greater London (region)
Wencker, Dominique (Dutscher 202108 CEO) Chief Executive Officer (CEO) Dutscher (DD) (Group) Grand Est (Great East) (region)
Wentworth, James (Transgene 202401– CBO before Adaptimmune + inVentiv Health + Shire + ViroPharma) Chief Business Officer (CBO) Mérieux (Group) Grand Est (Great East) (region)
Wermuth, Camille G. (Prestwick Chemical 200411 CSO + founder) Chief Scientific Officer (CSO) / Chief Development Officer (CDO) Bionomics (Group) Grand Est (Great East) (region)
Werner, Thomas (Board Member of several companies before GSK SVP) Board member, non-executive GSK (Group) Greater London (region)
Weß, Ludger (akampion before 2001–2006 BioCentury Senior Editor before Financial Times Deutschland) Public Relations Manager / Investor Relations Manager Akampion Hamburg (federal state)
Whelan, James P. (bioMérieux 201101– EVP Commercial Services before Magellan + ESA Biosciences before LabCorp + Fisher) Business Manager Mérieux (Group) Auvergne-Rhône-Alpes (region)
White, Janet (Lonza 201109 Head Development Services) President/Director/Head Business Group/Unit/Division Lonza (Group) Northwestern Switzerland (region)
White, Randy (Adnavance 200802– CEO before Nanogen CEO + Xenomics CEO before Executive VP American Medical Laboratories) Chief Executive Officer (CEO) Adnavance Technologies Inc. British Columbia
Whittingham, Jerel (Myconostica 200804 CEO) Chief Executive Officer (CEO) Novacyt (Group) North West England (region)
Wicke, Ilka (Boehringer 201203 Director at Boehringer Ingelheim Venture Fund) Investment Manager Boehringer Ingelheim (Group) Rheinland-Pfalz (federal state)
Wicki, Andreas (HBM Healthcare Investments 201402 CEO) Chief Executive Officer (CEO) HBM (Group) Central Switzerland (region)
Wiedemann, Sonja (Eurofins 201801 Managing Director at Eurofins Genomics GmbH) Managing Director Eurofins (Group) Bayern (federal state)
Wiest, Kajo (Humedics 202302 Manager Finance + Controlling) Chief Financial Officer (CFO) Humedics GmbH Brandenburg (federal state)
Wilking, Karsten (Polyplus-transfection 2017– CEO before Life Technologies/Applied Bisystems/Invitrogen) Managing Director Sartorius (Group) Grand Est (Great East) (region)
Williams, Dave (Sanofi Pasteur 200702 CEO) Chief Executive Officer (CEO) Sanofi (Group) [since May 2011]
WIlliams, Jeff (Clinipace 201504 CEO) Chief Executive Officer (CEO) Clinipace (Group) North Carolina (federal state)
Wilson, Dominic (Bryan Garnier 201709– Managing Director at European Healthcare division before Zeus Capital + Nomura) Managing Director Bryan, Garnier & Co., Ltd. Greater London (region)
Wilson, Ian (ImaginAb 201902– CEO joined 201802 as COO before Edinburgh Molecular Imaging + Xstrahl Ltd) Chief Executive Officer (CEO) ImaginAb Inc. California (federal state)
Windhab, Norbert n. a. Sanofi (Group) [since May 2011] Hessen (Hesse) (federal state)
Wisniewski, Raphaël (Andera Partners 202110 formerly LCF Rothschild at Edmond de Rothschild Investment Partners) Partner (venture partner) Andera Partners (FR) Île-de-France (region)
Wispenninckx, Jérome (Imlab 202205 CEO) Chief Executive Officer (CEO) Imlab (Group) Belgium_o
Witte, Sariette (Alentis Therapeutics 202309 Head of Communications) Public Relations Manager / Investor Relations Manager Alentis Therapeutics AG Northwestern Switzerland (region)
Witz, Pascale (Sanofi 201307–201605 EVP before GE Healthcare + Becton Dickinson LEFT 6/16) President/Director/Head Business Group/Unit/Division Sanofi (Group) [since May 2011] Île-de-France (region)
Woerle, Hans-Juergen (Boehringer 201706 Global VP Medicine) Chief Medical Officer (CMO) Nestlé (Group) Région Lémanique (region)
Woiwode, Tom (Versant Ventures 201404 before Synosis + Xenoport) Venture Partner Versant Ventures California (federal state)
Wojczewski, Christian (Evotec 202407– CEO before Mediq + Linde + McKinsey) Chief Executive Officer (CEO) Evotec (Group) Hamburg (federal state)
Woker, Mathias (AMSilk 201210– CBO located in Boston before Graffinity 200603 Senior VP BusDev US) Business Development Manager / Strategy Manager AMSilk GmbH Bayern (federal state)
Woler, Charles (Biomnis 201210– CEO before Endotis Pharma CEO) Chief Executive Officer (CEO) Eurofins (Group) Auvergne-Rhône-Alpes (region)
Woler, Charles (Neuro3d 200504 CEO) Chief Executive Officer (CEO) Evotec (Group) Grand Est (Great East) (region)
Wolikow, Nicolas (Cure51 202403 CEO + Co-Founder) Chief Executive Officer (CEO) Cure51 SAS Île-de-France (region)
Wood, Christopher B. (Chris) (NuCana Biomed 2008– Executive Chair + Co-founder before Bioenvision 1999–2007 CEO) Chief Executive Officer (CEO) NuCana plc (Nasdaq: NCNA) Scotland
Wood, Clive R. (Boehringer 201403– SVP Discovery Research before Bayer HealthCare + Dyax) President/Director/Head Business Group/Unit/Division Boehringer Ingelheim (Group) Rheinland-Pfalz (federal state)
Wood, Michael (LifeSci Advisors 2014) Public Relations Manager / Investor Relations Manager LifeSci (Group) New York (federal state)
Woodman, Rob (Panakès Partners 202109– Partner to lead biotech team before Takeda Ventures + Imperial Innovations) Partner (venture partner) Panakès Partners (Group) Lombardia (Lombardy)
Wren, John (Omnicom 201307 CEO) Chief Executive Officer (CEO) Omnicom (Group) New York (federal state)
Wright, Fraser (Yposkesi 201807– Senior Advisor before co-founder + CTO of Spark Therapeutics + Avigen) Consultant (economic/technology) SK Group (Group) Île-de-France (region)
Wurm, Florian (ExcellGene 200905 CSO + founder) Chief Scientific Officer (CSO) / Chief Development Officer (CDO) ExcellGene S.A. Région Lémanique (region)
Wuurman, Bart (Apaxen 202011– CEO before Lyramid + Lanthio Pharma + AM-Pharma + De Novo Pharma + Antisoma) Chief Executive Officer (CEO) Apaxen S.A. Wallonia (region)
Xia, Ning (Chemical.AI 202101 CEO) Chief Executive Officer (CEO) Chemical.AI (Wuhan Zhihua Technology) (Group) Hubei (Hupeh) (province)
Yamanaka, Shinya (Univ Kyoto 201004– Director of CiRA + Nobel Laureate 2012) Professor University of Kyoto (Kyoto University) Kinki (region)
Yanai, Shlomo (Teva 200706 President + CEO) Chief Executive Officer (CEO) Teva (Group) Israel_o
Yancopoulos, George D. (Regeneron 200703 CSO + Co-Founder) Chief Scientific Officer (CSO) / Chief Development Officer (CDO) Regeneron (Group) New York (federal state)
Yang, Jerry (HCVC 202211 General Partner) General Partner (venture partner) HCVC (Hardware Club VC) Île-de-France (region)
Yao, Zhizhong (Joel) (Sofinnova 202312 Partner in Biovelocita initiative) Partner (venture partner)
Yasri, Aziz (OriBase Pharma 201403 CEO + Founder) Chief Executive Officer (CEO) PPF Group (Group) Occitanie (Occitania) (region)
Ybert, Thomas (DNA Script 201709 CEO + Co-Founder) Chief Executive Officer (CEO) DNA Script (Group) Île-de-France (region)
Yerganian, Syrane (Strammer 201704 CFO) Chief Executive Officer (CEO) Strammer (Group) Île-de-France (region)
Yoder, Stephen S. (Steve) (Pieris 201001– CEO before MorphoSys Head Licensing + IP) Chief Executive Officer (CEO) Pieris (Group) Bayern (federal state)
You, Angie (Amunix Pharmaceuticals 202103 CFO) Chief Executive Officer (CEO) Sanofi (Group) [since May 2011] California (federal state)
Young, Joshua (Bruker 201301– VP Investor Relations before Merck KGA + Millipore LEFT BEFORE 7/16) Public Relations Manager / Investor Relations Manager Bruker (Group) Massachusetts (federal state)
Young, Steve (200607 MDL Director Content Strategy) n. a. Dassault Systèmes (3DS) (Group) California (federal state)
Yu, Frank (Ally Bridge Group 201702 CEO + CIO + Founder) Chief Executive Officer (CEO) Ally Bridge Group (ABG) Hong Kong (province)
Yu, Michael (Innovent Biologics 202208 CEO + Founder) n. a.
Yu, Yuexin (Andera Partners 202201 Investment Director at Andera Life Sciences) Investment Manager Andera Partners (FR) Île-de-France (region)
Yusupov, Marat (CNRS 201911 Research Director at IGBMC in Strasbourg) Researcher (university / research institute) University of Strasbourg Grand Est (Great East) (region)
Yusupova, Gulnara (CNRS 201911 Research Director at IGBMC in Strasbourg) Researcher (university / research institute) University of Strasbourg Grand Est (Great East) (region)
Yvon, Pascal (S-Biomedic 202208– SVP Commercial Strategy + Sales before Croda Inc) Sales Manager / Marketing Manager Beiersdorf (Group) Flanders (Flemish region)
Zacho, Helle (Dutscher 202304– CEO of AH Diagnostics joined as CSO in 2017 before Novo Nordisk) Chief Executive Officer (CEO) Dutscher (DD) (Group) Denmark_o
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25  next pagenext page



Advertisement

Picture Berlin Partner BIO 2024 International Convention San Diego 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture Berlin Partner Top News Healthtech Company Mika 650x300px

» top